We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High Fat Diet Corrects Mitochondrial Dysfunction in Premature Aging Mouse Model

By LabMedica International staff writers
Posted on 12 Jul 2015
Metabolic disease researchers used a progeroid syndrome mouse model that exhibited symptoms of mitochondrial dysfunction to demonstrate the link between mitochondrial stress and the hormone FGF21 (fibroblast growth factor 21).

Progeroid means "resembling premature aging", and the progeroid POLG (polymerase gamma mtDNA mutator) mouse model was used by investigators at the Salk Institute (La Jolla, CA, USA) to study mitochondrial disease and premature aging. More...


These mice exhibited signs of metabolic imbalance including thermogenic defects in brown adipose tissue (BAT). A side effect of this adaptive response was the complete resistance to diet-induced obesity displayed by POLG mice when they were placed on a high-fat diet (HFD). Surprisingly, HFD further increased oxygen consumption in part by inducing thermogenesis and mitochondrial biogenesis in BAT along with enhanced expression of fibroblast growth factor 21 (FGF21).

FGF21 is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. Treatment of animals with FGF21 resulted in increased energy expenditure, fat utilization, and lipid excretion.

The investigators reported in the June 29, 2015, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that the metabolic benefits induced by mild mitochondrial stress via FGF21 induction in POLG mice fed a high-fat diet enabled those mice to resist diet-induced obesity and its underlying associated disease states. In addition, nutrients from a HFD appeared to reverse metabolic imbalance in these mice. HFD also robustly increased fat metabolism and improved mitochondrial function in brown fat, which mediated adaptive thermogenesis.

"These findings help us understand the link between diet, health, and aging, and they give us the potential to dissect these connections in a molecular way that could lead to therapeutics," said senior author Dr. Ronald Evans, director of the gene expression laboratory at the Salk Institute. "What we believe now is that turning on FGF21 is an adaptation to help this animal maintain its metabolic health. If the mice did not have this hormonal "fountain of youth," they might age even more quickly than they already do."

Related Links:

Salk Institute



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology System
Medonic M16C
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.